Artiva Biotherapeutics said it will eviscerate its workforce 94% and evaluate strategic options after two patients treated ...

Study uncovers the Vanin-pantethine-cholesterol axis as a key metabolic pathway governing dendritic cell activation.

Uduak Thomas, Senior Editor at GEN, took a minute away from the talks, posters, and expo hall to join Julianna LeMieux, PhD, ...

Scaling the science into any kind of business “is just really tough, but scaling a biotechnology company in South Africa is ...

Anthropic plans to expand its growing presence in life sciences by investing further in knowledge, talent, partnerships, and ...

The collective activity of all six genes, which the researchers called the PHFScore, divided patients into groups with ...

Closing the execution gap is one of the greatest opportunities biopharma has today to enhance resilience and unlock the full ...

The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both said today, in a deal that would take private the global life-sciences ...

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

Pluristyx leaders outline how better starting materials, automation, and process control can scale iPSC manufacturing.

Gene therapy firms need to consider patients when choosing a viral vector production method, say researchers behind new economic analysis.